Wearables: A device for poor posture, baby monitors under academic scrutiny;

@FierceMedDev: ICYMI yesterday: Brain tumor treatment device gets early trial halt for efficacy as a combo with chemo. Story | Follow @FierceMedDev

@EmilyWFierce: Shaq is back for $SNY's latest marketing campaign. Release | Follow @EmilyWFierce

> Corpak MedSystems, a medical device company focused on enteral access technologies, acquired France-based Maxter Catheters, developer of disposable medical devices, for an undisclosed amount. Release

> An academic points out that there is no FDA approval or published data supporting claims that wearable baby monitors prevent sudden infant death syndrome (SIDS). Release

> South Korean company creates Arki, a wristband that uses arm swing patterns to detect bad posture and alerts wearer to adjust their posture. Watch

> CoorsTek Medical acquired Italian device manufacturer Nanosurfaces Industries for an undisclosed amount. Release

Biotech News

@FierceBiotech: Agios offers another glimpse of 'exciting' early data for a leukemia drug. Report | Follow @FierceBiotech

@JohnCFierce: Lots of discussion about this one -- Average cost of drug R&D? Try $2.9B on for size. Editor's Corner | Follow @JohnCFierce

@DamianFierce: Knight Therapeutics found a buyer for its FDA priority review voucher, selling it to $GILD for $125M. Release | Follow @DamianFierce

> Sanofi's shortlist of CEO candidates so far has a distinct French accent. Item

> Shire orders 500 staffers to move to Boston-area biotech 'Mecca.' Report

> Bind heralds hope for its nanotech cancer drug after mixed Phase II. Story

> Go-go execs at Gilead nab an FDA priority review voucher for $125M. News

Pharma News

@FiercePharma: Ranbaxy fights FDA for killing its approval to make generic Nexium. FiercePharmaManufacturing story | Follow @FiercePharma

@CarlyHFierce: AirFluSal Forspiro won approval in my two favorite countries, Ireland & Czech Republic, which is inconsequential to me but fun nonetheless. | Follow @CarlyHFierce

> Novartis seeks tech partners for brave new beyond-the-pill world. More

> Solo Shire moves 500 to Boston as it pushes ahead with reorg. Story

> NICE asks Novartis to pony up more information on Xolair for hives. Report

Drug Delivery News

> Cynapsus releases clinical trial data about its sublingual thin-film strip for Parkinson's. Item

> Catalent buys particle engineering outfit Micron Technologies. News

> RNAi masking technique allows more efficient delivery. Story

> Medical marijuana company licenses RapidMist device for buccal delivery. Report

> NSF funds further research into only FDA-cleared catheter for rectal delivery. Article

Diagnostics News

> Precision Therapeutics ropes in $60M for corporate overhaul. More

> Cepheid snags $3.3M to roll out rapid Ebola test. Report

> Roche nabs FDA clearance for quick strep test. News

> Illumina, Sequenta partner up on next-gen cancer diagnostic. Article

> Enterome teams up with AbbVie to create molecular Dx for Crohn's disease. Item

Pharma Marketing News

> Payers' hep C delay tactics work: Coverage hurdles may be dampening Harvoni script growth. Article

> How to prep for a 'megablockbuster' launch? Novartis lines up cost-savings data. Report

> Valeant and Allergan's wining-and-dining shows docs still hold the script reins. More

> Painkiller marketing secrets? Check Chicago's unredacted suit against Endo, Purdue, Cephalon, et al. Story

> Sanofi tags newly OK'd MS drug Lemtrada at $158K, ready to tout head-to-head Rebif data. Article

Suggested Articles

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.